isomethyleugenol has been researched along with Iron Overload in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Malcovati, L | 1 |
| Cmejla, R; Cmejlova, J; Elleder, M; Man, P; Myslivcova, D; Petrak, J; Vulpe, CD; Vyoral, D | 1 |
1 review(s) available for isomethyleugenol and Iron Overload
| Article | Year |
|---|---|
Red blood cell transfusion therapy and iron chelation in patients with myelodysplastic syndromes.
Topics: beta-Thalassemia; Deferiprone; Disease Progression; DNA Methylation; Erythrocyte Transfusion; Erythrocytes; Ferritins; Humans; Immunosuppressive Agents; Iron Chelating Agents; Iron Overload; Methylation; Myelodysplastic Syndromes; Pyridones; Risk; Treatment Outcome | 2009 |
1 other study(ies) available for isomethyleugenol and Iron Overload
| Article | Year |
|---|---|
Proteomic analysis of hepatic iron overload in mice suggests dysregulation of urea cycle, impairment of fatty acid oxidation, and changes in the methylation cycle.
Topics: Animals; Disease Models, Animal; Electrophoresis, Gel, Two-Dimensional; Enzymes; Fatty Acids; Iron Compounds; Iron Overload; Liver; Liver Diseases; Male; Methylation; Mice; Mice, Inbred C57BL; Oxidation-Reduction; Proteomics; Severity of Illness Index; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Urea | 2007 |